ADIPOQ and type 2 diabetes mellitus: In contrast, lower serum levels of adiponectin are associated with T2D, cardiovascular disease, and insulin resistance, although the levels increase when T2D patients undergo post-gastric bypass surgery for visceral fat reduction [6,7].